We recently published 10 Big Names Leading Wall Street Gains. Sarepta Therapeutics Inc. (NASDAQ:SRPT) is one of the ...

Moderna Inc. continues to push its cost-savings work as Covid-19 vaccination rates decline. The company's third-quarter 2025 ...

The FDA declined to consider elamipretide for full approval in 2021 and rejected the company's application in May of 2025 ...

The complete response letter has not yet been posted to the FDA website, but according to Biohaven, the agency rejected its ...

Major U.S. equities indexes slumped Thursday afternoon, led by tech stocks after a flurry of earnings reports and as worries ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

By Hannah Lang (Reuters) -Crypto giant Ripple supports the idea of a "skinny" Federal Reserve payments account for non-banks, ...

US stocks dip as bank CEOs warn of a 10–15% pullback; tech stocks drag Nasdaq and S&P500 lower, raising concerns over ...

(Reuters) -Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House ...

Heart & Stroke, in partnership with Brain Canada, is proud to announce funding for the third Research Network of Excellence ...

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes ...

Sarepta said DMD treatments Amondys 45 and Vyondys 53 show 'positive and encouraging trends' even though a trial failed to ...